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minireview will attempt to summarize and evaluate these
recent results as well as to draw comparisons with two
other molecules that undergo similar patterns of proteol-
ysis: sterol regulatory element binding protein (SREBP)
and the b-amyloid precursor protein (APP).
Yee-Ming Chan and Yuh Nung Jan
Howard Hughes Medical Institute and
Departments of Physiology and Biochemistry
University of California, San Francisco
San Francisco, California 94143-0725
Genetic Evidence for Nuclear Access of Notch
The proteolysis model of Notch signaling makes several
The Notch receptor family includes Notch in Drosophila,
predictions: (1) cleavage to release the NICD occurs if
LIN-12 and GLP-1 in C. elegans, and mNotch1 and
and only if the Notch receptor is activated, (2) the re-
mNotch2 in mouse, among others (for reviews, see Arta-
leased NICD is present in the nuclei of cells, (3) the NICD
vanis-Tsakonas et al., 1995; Kimble and Simpson, 1997;
can activate transcription, and (4) blocking cleavage of
Greenwald, 1998). During development, Notch mediates Notch, nuclear localization of the NICD, or the ability of
cell±cell communications required for a variety of cell the NICD to activate transcription blocks Notch signal
fate decisions and for axon guidance. Notch family
transduction. Various groups have demonstrated the
members are multidomain proteins that consist of a
ability of intracellular fragments of Notch to activate
single transmembrane domain and large extracellular transcription as well as the importance of nuclear local-
and intracellular domains. The ligands for Notch are ization for this activity, and such work has provided
single-pass transmembrane proteins of the DSL family indirect support for the proteolysis model. The main
(Delta/Serrate/LAG-2). Members of the CSL family (CBF1/ objection to the proteolysis model is that Notch cannot
Suppressor of Hairless/LAG-1) are transcription factors be detected in the nuclei of wild-type cells by immuno-
that function downstream of Notch and serve to activate fluorescence. This complication adds a fifth prediction:
downstream targets such as genes in the E(spl) (En- the NICD functions in nuclei at a concentration below
hancer of split) complex in Drosophila and HES (Hairy/ that detectable by immunofluorescence.
Enhancer of split) genes in mammals. In some instances To overcome the limited sensitivity of immunofluores-
in Drosophila development and mammalian cells, how- cence, Struhl and Adachi (1998) and Lecourtois and
ever, Su(H) (Suppressor of Hairless) and CBF1, respec- Schweisguth (1998) usesimilar, clever geneticstrategies
tively, are not required for Notch signaling. The down- to detect nuclear Notch in Drosophila. Struhl and Adachi
stream effectors of Notch signaling in these situations create a construct (N1-GV3) in which the DNA-binding
are unknown. domain of the yeast Gal4p and the transcriptional activa-
The molecular mechanism by which Notch signaling tion domain of the viral protein VP16 are inserted just
results in the transcriptional activation of downstream C-terminal to the transmembrane domain of full-length
targets has remained mysterious. Deletion analyses of Notch. The authors find that expression of this construct
Notch showed that intracellular fragments of Notch have in embryos results in transcription of a reporter gene
constitutive activityand, to the surprise of many, localize under control of Gal4p-binding sites (also called UAS
to the nucleus. These findings led Struhl et al. (1993) for upstream activation sequence). Their result demon-
and Lieber et al. (1993) to propose the proteolysis model strates that Gal4/VP16, though originally tethered to the
of Notch signaling. The model states that ligand binding membrane by Notch, gains access to DNA in the nu-
results in proteolytic cleavage of Notch and consequent cleus. The most plausible mechanism for this access is
release of the Notch intracellular domain (NICD). The proteolysis to release the NICD and subsequent nuclear
NICD then enters the nucleus and associates with CSL entry, as predicted by the proteolysis model. Struhl and
proteins at target genes and activates transcription ei- Adachi show, using a constitutively active form (NECN-
ther directly or indirectly through another factor such GV3) and two inactive forms of Notch (NSev11-GV3 and
as CSL. NEGF-GV3), that the ability of the constructs to activate
An alternative tethering model of Notch signaling was transcription of the reporter correlates with their ability
proposed by Fortini and Artavanis-Tsakonas (1994), who to rescue the cuticle defects of Notch mutant embryos.
demonstrated that Su(H) is present in the cytoplasm of Consistent with the prediction that the NICD works at
cultured Drosophila cells that expressNotch but translo- low levels, Struhl and Adachi fail to detect nuclear Gal4
cates to the nucleus when these cells are mixed with even in situations in which Gal4 activity is detectable.
cells expressing the ligand Delta. The tethering model Lecourtois and Schweisguth generate a similar full-
states that the primary function of Notch is to tether length Notch-Gal4 construct (Gal4-Nfl) but insert only
Su(H) in the cytoplasm and to release Su(H) upon ligand the Gal4p DNA-binding domain just C-terminal to the
binding. In the simplest form of this model, Notch acts Notch transmembrane domain. They find that this con-
as a negative regulator of Su(H), but loss of Notch and struct also activates transcription of a UAS reporter.
loss of Su(H) result in the same phenotype. Notch must Struhl and Adachi test a similar construct (N1-G4) and
therefore also act as a positive regulator of Su(H) in a obtain similar results. These results demonstrate that
manner unspecified by the model. in these assays the NICD has the ability to activate
Recent reports from several groups provide evidence transcription when bound to DNA. Struhl and Adachi
in support of the proteolysis model of Notch signaling. further test constructs in which a transcriptional repres-
In addition, recent work describes roles for proteolysis sion domain is inserted along with the Gal4p DNA-bind-
ing domain in the Notch intracellular domain (N1-G4,and trafficking of Notch during receptor maturation. This
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enRep and N1-G4, WRPW). Such constructs fail to acti- and that this cleavage can be blocked by protease inhib-
itors. The Kopan group further characterizes this cleav-vate the UAS reporter and do not rescue Notch mutant
phenotypes. The finding that the addition of a transcrip- age in a recent paper (Schroeter et al., 1998). Using
agents that block vesicle trafficking, the authors findtional repression domain blocks Notch activity strongly
suggests a role for the NICD in the nucleus. that cleavage to produce the NICD occurs after Notch
reaches the plasma membrane.Lecourtois and Schweisguth test a construct (Gal4-
Nintra) similar to Gal4-Nfl but lacking the extracellular and While the NICD produced from NotchDE is readily visu-
alized on Western blotting, it has not been observed intransmembrane domains and find that this construct
exhibits constitutive Notch activity and constitutively extracts from cells expressing full-length Notch. The
authors find that they can enrich for the NICD by coim-activates a UAS reporter. They further find that this acti-
vation is absent in embryos mutant for Su(H), which munoprecipitation with RBP3, the mouse CSL. They
then exploit this enrichment to visualize clearly the NICDencodes the Drosophila CSL. This result suggests that
the NICD may not possess an intrinsic transcriptional on Western blots of extracts from cells expressing
NotchFL. They further demonstrate that cleavage to pro-activation activity but instead activates transcription in-
directly through Su(H). Alternatively, the NICD may re- duce the NICD occurs only if constructs encoding
NotchFL and the ligand Jagged1 are cotransfected. (Toquire Su(H) during some upstream step, such as nuclear
localization. In their experiment, however, it is possible demonstrate that intercellular signaling is necessary for
cleavage, a better experiment would be to expressthat their hybrid promoter (m5UAS) requires Su(H), not
the NICD itself. Follow-up experiments should quickly NotchFL and Jagged1 in separate populations of cells
and then to mix them.) The authors also test the predic-resolve this issue.
Both groups find that their full-length Notch-Gal4 con- tion that the NICD can function at very low levels by
expressing an intracellular construct (NotchICV1744) at sev-structs do not activate transcription of UAS reporters in
embryos mutant for Delta, which encodes the embryonic eral expression levels, detecting this construct using
the six-Myc tags, and assaying transcription from theNotch ligand. Lecourtois and Schweisguth show that
transcriptional activation by Gal4-Nfl still occurs in em- HES-1 promoter. The authors thereby show quantita-
tively that the NICD can indeed activate transcription atbryos mutant for the Notch downstream target E(spl),
even though such embryos exhibit the same phenotype concentrations far below that detectable by conven-
tional immunocytochemistry.as Delta mutant embryos. These results show that the
inability of Gal4-Nfl to activate transcription in Delta mu- A Role for Cytoplasmic/Transmembrane
Proteolysis in Notch Signalingtant embryos is due directly to loss of Delta rather than
to secondary effects due to loss of Notch signaling. The genetic and biochemical results described above
provide at best a strong correlation between Notch pro-Struhl and Adachi also rescue transcription of a UAS
reporter in the absence of Notch signaling by expressing cessing and Notch signaling, but they do not provide
functional evidence that proteolysis is required for sig-Delta from a transgene at a time too late to rescue the
Delta mutant phenotype. naling. Schroeter et al. (1998) go on to provide such
evidence. By N-terminal peptide sequencing, the au-Lecourtois and Schweisguth's experiment leaves open
the possibility that the ability of the NICD to activate thors find that the NICD is produced by cleavage before
a conserved valine residue that lies either within or justtranscription, rather than its nuclear access, requires
Delta. Since Struhl and Adachi's construct contains a C-terminal to the transmembrane domain. The authors
proceed to generate a construct based on NotchDE inVP16 activation domain and therefore does not require
the transcriptional activation activity of the NICD, their which this conserved valine is replaced by a leucine
or a lysine. This mutant construct, which contains theresult demonstrates that nuclear access itself is depen-
dent on Delta. These results are consistent with the transmembrane domain, exhibits reduced ability todrive
expression from a HES-1 promoter as well as reducedprediction that proteolysis of Notch occurs only when
the receptor is activated by binding its ligand Delta; it efficiency of NICD generation. In contrast, mutation of
the cleavage site valine does not block the activity of ais still possible that ligand binding is also required for
some other aspect of Notch activation. mNotch1 construct that does not contain a transmem-
brane domain (NotchICV1744). This critical control demon-Biochemical Evidence for Proteolysis to Release
the Notch Intracellular Domain strates that the cleavage site valine is not required for
activities of Notch once it has been released from theKopan et al. (1996) present direct biochemical evidence
that Notch is cleaved to release the NICD. The authors membrane and, taken with the authors' other results,
upholds the prediction that blocking proteolysis blocksexpress in cultured mammalian cells a constitutively
active form of mNotch1 inwhich the extracellular domain Notch signaling. The authors' findings are somewhat
weakened, however, by the fact that they assay proteol-is deleted but the transmembrane domain is left intact
(NotchDE). The authors also replace the C-terminal z300 ysis and signaling in different cell types.
The strong correlative evidence provided by all theamino acids of Notch with six Myc tags to increase the
stability of the protein and to facilitate its detection. above groups and the functional data provided by
Schroeter et al. (1998) make a strong case for the prote-They observe that, even though NotchDE possesses a
transmembrane domain, it is detectable in cell nuclei by olysis model of Notch signaling. All groups, however,
make use of artificial constructs and reporters, and crit-immunocytochemistry. Western blot and pulse-chase
analyses demonstrate that a 63 kDa peptide, which is ics will demand demonstration in vivo of ligand-depen-
dent processing of wild-type Notch and its importancethe size predicted for the NICD generated from their
construct, is produced as a result of cleavage of NotchDE for signaling. Such demonstration may be difficult, but
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the identification of the protease responsible for the
cleavage will allow genetic experiments that address
this issue.
Roles for Extracellular Proteolysis in Receptor
Maturation and Notch Signaling
In addition to the cleavage to produce the NICD, cleav-
age also occurs in the Notch extracellular domain. Blau-
mueller et al. (1997) detect a z115 kDa membrane-asso-
ciated fragment of mNotch2 on Westernblots in addition
to z300 kDa full-length mNotch2. The authors observe
similar fragments of mNotch1 and Drosophila Notch.
Based on its molecular weight, membrane association,
and kinetics of generation, the authors conclude that
this transmembrane fragment, which they term NTM, is
produced by cleavage of Notch in the extracellular do-
main. By using various treatments to block vesicle traf-
ficking, the authors demonstrate that this extracellular
cleavage occurs in the trans-Golgi network. A z180 kDa
peptide coimmunoprecipitates with NTM and is gener-
ated with the same kinetics as NTM, and the authors
surmise that this peptide, which they name NEC, is the
extracellular fragment of mNotch2 produced by the ex-
tracellular cleavage. The authors propose that the NTM/NEC
heterodimer is the form of the Notch receptor that binds
ligand, and in support of this hypothesis they show that Figure 1. Models of Proteolytic Processing of Notch, SREBP, and
NTM, but not full-length Notch, is present at the cell sur- APP
face and that Delta coimmunoprecipitates with NTM. (A) IsraeÈ l's three-step model of Notch proteolysis. Notch is first
A recent report by the IsraeÈ l group (Logeat et al., cleaved in its extracellular domain at site 1 by furin in the trans-
Golgi to generate NEC and NTM, which heterodimerize to form the cell1998) demonstrates that furin is the protease directly
surface receptor. Upon ligand binding, Notch is then cleaved in itsresponsible for this cleavage. The authors, working with
extracellular domain at site 2. The second cleavage triggers cleav-mNotch1 in cultured mammalian cells, confirm the re-
age in its intracellular or transmembrane domain at site 3 to releasesults of Blaumueller et al. (1997) and unambiguously
the Notch intracellular domain (NICD). The epidermal growth factor
identify the NTM/NEC heterodimer as the cell surface re- (EGF) repeats, LIN-12/Notch (LN) repeats, CDC10/ankyrin repeats,
ceptor. They further show that purified furin can cleave and the opa region of Notch are indicated.
(B) Two-step activation of SREBP. In response to low cholesterolpurified mNotch1 in vitro, that a cell line lacking furin is
levels, SCAP activates cleavage of SREBP at site 1, which lies inunable to cleave mNotch1, and that mutation of the main
the luminal domain. This cleavage in turn triggers cleavage in thefurincleavage site, which lies in theextracellular domain,
N-terminal transmembrane domain by the S2P metalloprotease at
blocks the Notch extracellular cleavage in cells. The site 2 to release the N terminus, which encodes a transcription factor
IsraeÈ l group also has early evidence for a second extra- of the basic-helix-loop-helix (bHLH) class.
cellular cleavage that can be blocked by metallopro- (C) Proteolysis of APP. APP is cleaved at one of two extracellular
sites by either the a- or the b-secretase activity. Extracellular cleav-tease inhibitors (see Bray, 1998). IsraeÈ l hypothesizes
age in turn triggers cleavage by the g-secretase activity in the trans-that this second extracellular cleavage event occurs in
membrane domain. Cleavages by the b-secretase activity followedresponse to ligand binding and in turn triggers the intra-
by the g-secretase activity release the amyloid b (Ab) peptide.cellular/transmembrane cleavage to release the NICD.
Indeed, the Kopan group's NotchDE construct, which
lacks the extracellular domain, is constitutively cleaved,
however (see Logeat et al., 1998). It therefore remainspossibly because it mimics a Notch molecule that has
to be determined conclusively whether Kuz is requiredbeen cleaved at the second extracellular site.
for Notch processing or for some other aspect of NotchThe Drosophila kuzbanian (kuz) gene appears to have
signaling, whether Kuz cleaves Notch directly, and whata role in the extracellular cleavage of Notch. Animals in
the relationship is between Kuz and furin.which kuz function is disrupted have Notch-like defects
Models of Proteolysis: Notch, SREBP, and APPin lateral inhibition, cell-fate determination, axon guid-
IsraeÈ l proposes a three-step model of Notch activationance, and wing development. kuz encodes a metallopro-
(Figure 1A). The first step is proteolysis at the first extra-tease of the ADAM (a disintegrin and metalloprotease
cellular site to produce the NTM/NEC heterodimer; thisdomain) family, and Kuz-like proteases have been found
cleavage occurs in the trans-Golgi during receptor mat-in mouse (MKUZ) and C. elegans (SUP-17). Pan and
uration and is catalyzed by furin. Ligand binding at theRubin (1997) report that Drosophila embryos and cul-
cell surface triggers the second step, cleavage at thetured cells in which Kuz activity is disrupted fail to pro-
second extracellular site, which in turn triggers the thirdduce a z100 kDa fragment of Notch that may corre-
step, proteolysis at the transmembrane/intracellular sitespond to NTM. Taken at face value, this result indicates
to release the NICD. How ligand binding causes proteol-that Kuz is required for the first extracellular cleavage
ysis and how proteolysis at the second extracellular siteof Notch and presumably operates upstream of furin.
This particular result of Pan and Rubin is controversial, triggers the cleavage to release the NICD are unknown.
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This proteolysis model of Notch activation closely re- since Notch receptor maturation requires proper intra-
sembles that described for SREBP (sterol regulatory cellular transport.
element binding protein; for review, see Brown and Notch, SREBP, and APP may therefore share a pat-
Goldstein, 1997). SREBP is an endoplasmic reticulum tern of a regulated extracellular cleavage that triggers
protein with two transmembrane domains and under- a transmembrane/intracellular cleavage. This shared
goes two successive proteolytic cleavages (Figure 1B). pattern and the role of the presenilins raise the excit-
Proteolysis of SREBP in its luminal domain occurs in ing possibility of common components and processes
response to low intracellular cholesterol levels and is shared by the three proteins. There may be differences
activated by SREBP cleavage activating protein (SCAP). between the processing of the three proteins, however.
This regulated proteolysis triggers a second cleavage For example, the two extracellular cleavages of Notch
in the N-terminal transmembrane domain catalyzed by are proposed to be required in succession, while the two
the S2P metalloprotease (Rawson et al., 1997). As a extracellular cleavages of APP are mutually exclusive.
result, the N terminus of SREBP is released from the Further research will reveal whether there are more simi-
endoplasmic reticulum membrane into the cytoplasm larities or differences between Notch, SREBP, and APP
and translocates to the nucleus. Unlike the NICD, which processing.
does not bind DNA and may activate transcription only Toward a More Complete Model of Notch Signaling
indirectly, the SREBPN terminus is a bona fide transcrip- The results summarized in this minireview provide a
tion factor of the basic-helix-loop-helix class and binds basic skeleton for the proteolysis model of Notch activa-
directly to target genes to activate their transcription. tion. The challenge for researchers now is to confirm
There are also similarities between the proposed pro- aspects of the model in vivo, to flesh out details of the
cessing of Notch and that of the b-amyloid precursor model, to identify and assign functions to the molecules
protein (APP). Three proteolysis events have been de- involved in Notch signaling, and to integrate the model
scribed for APP (Figure 1C; for review, see Selkoe,1994). with previous work on Notch signaling. It also remains
Proteolysis of APP in its extracellular domain by the so- to be determined whether the proteolysis model is true
called a-secretase activity generates a soluble form of for Notch signaling in all contexts, particularly those in
APP (APPs) that appears in some settings to be the which Notch signaling is independent of Su(H) or CBF1.
bioactive form of APP. An alternative extracellular cleav-
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